Clinical Trial Update: Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot study at MD Anderson is evaluating topical capsaicin for pain from chemotherapy-induced peripheral neuropathy; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Topical capsaicin (capsaicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Peripheral Neuropathy Due to Chemotherapy | EARLY_Phase 1 | Status: RECRUITING